Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression R33

Brief description of study

~60 subjects with MDD will undergo MRI scanning during t-PBM (administered with an irradiance of 291.7 mW/cm2 for 333s) before and after a randomized, double-blinded, controlled 16-session course of treatment with t-PBM or sham. t-PBM will be administered via NeuroThera’s LightForce® EXPi Deep Tissue Laser TherapyTM System, Transcranial PhotoBioModulation-1000 (tPBM-2.0).


Clinical Study Identifier: s22-01065
ClinicalTrials.gov Identifier: NCT05573074
Principal Investigator: Dan Iosifescu.
Other Investigator: Thaddeus Tarpey.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.